B

BEVC

North America, California, United States, Berkeley

Description

BEVC invest in pioneers transforming cutting-edge science into disruptive companies.

Investor Profile

BEVC has made 4 investments, with 3 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (75%)
  • Series A (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Biopharma
  • Life Science
  • Pharmaceutical
  • Therapeutics
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BEVC frequently co-invest with?

venBio Partners
North America, California, United States, San Francisco
Co-Investments: 1
KdT Ventures
North America, Texas, United States, Austin
Co-Investments: 2
Playground Global
North America, California, United States, Palo Alto
Co-Investments: 1
MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Civilization Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Sahsen Ventures
North America, Washington, United States, Seattle
Co-Investments: 1
BV
Europe, Luxembourg, Belgium, Luxembourg
Co-Investments: 1
NFX Bio
North America, California, United States, San Francisco
Co-Investments: 1
Axial VC
North America, California, United States, San Francisco
Co-Investments: 1
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 1

Which angels does BEVC often collaborate with?

MZ
North America, United States
Shared Deals: 1

What are some of recent deals done by BEVC?

Montara Therapeutics

San Francisco, California, United States

Montara Therapeutics is a biotechnology company.

BiopharmaBiotechnologyMedicalWellness
SeedMar 13, 2025
Amount Raised: $20,000,000
PinkDx

Indianapolis, Indiana, United States

PinkDx is a biotechnology company.

BiopharmaBiotechnology
Series AJan 23, 2025
Amount Raised: $5,000,000
Radar Therapeutics

Berkeley, California, United States

Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.

MedicalTherapeutics
SeedMay 23, 2024
Amount Raised: $13,400,000
Insamo

Berkeley, California, United States

Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides at an unprecedented scale.

BiotechnologyLife SciencePharmaceutical
SeedFeb 21, 2024
Amount Raised: $12,000,000